TABLE 1.
Summary information on characteristics of studies contributing to main analysis
n/median (%/IQR) | |
---|---|
N total trials | 169 |
Sample size, median (IQR) | 126 (65‐251) |
Age (y), median (IQR) | 49 (45‐56) |
% Female, median (IQR) | 73 (51‐100) |
Mean BMI (kg/m2), median (IQR) | 34 (31‐36) |
Number of arms contributing to analysis, n studies (%) | |
2 | 136 (80) |
3 | 27 (16) |
4 | 4 (2) |
6 | 1 (1) |
7 | 1 (1) |
Geographical region, n (%) | |
North America | 94 (56) |
South America | 2 (1) |
Europe | 52 (31) |
Asia | 7 (4) |
Australia and New Zealand | 0 (0) |
Africa | 12 (7) |
Mixed (Australia and Europe) | 1 (1) |
Missing | 1 (1) |
Selection based on disease status, n (%) | |
No | 98 (58) |
Yes | 70 (41) |
Missing | 1 (1) |
Recruitment method, n (%) | |
Self‐initiated | 67 (40) |
Prompted | 72 (43) |
Missing | 30 (18) |
Random sequence generation (selection bias), n (%) | |
Low | 101 (60) |
Unclear | 67 (40) |
High | 1 (1) |
Allocation concealment (selection bias), n (%) | |
Low | 63 (37) |
Unclear | 106 (63) |
High | 0 (0) |
Blinding of outcome (detection bias), n (%) | |
Low | 147 (87) |
Unclear | 14 (8) |
High | 8 (5) |
Incomplete outcome data (attrition bias), n (%) | 169 (100) |
Low | 141 (83) |
Unclear | 7 (4) |
High | 21 (12) |
Other bias, n (%) | |
Low | 2 (1) |
Unclear | 13 (8) |
High | 17 (10) |